News & Updates
Filter by Specialty:
Neoadjuvant chemo plus durvalumab improves survival in NSCLC
The addition of durvalumab to neoadjuvant chemotherapy with cisplatin and docetaxel results in better survival rates among patients with resectable nonsmall cell lung cancer (NSCLC), according to a study presented at ELCC 2025.
Neoadjuvant chemo plus durvalumab improves survival in NSCLC
30 Apr 2025
SOF/VEL combo improves well-being of children with CHC
In children with chronic hepatitis C (CHC), effective treatment with sofosbuvir/velpatasvir (SOF/VEL) results in improvements in certain areas of their well-being at 1 year. This suggests some patient-reported outcomes (PRO) benefits of direct-acting antiviral (DAA) therapy. However, the parents’ proxy reports show a decrease in the patients’ school functioning.
SOF/VEL combo improves well-being of children with CHC
27 Apr 2025
Progestin-only contraceptives may pose NAFLD risk among women with GDM history
The use of progestin-only contraceptives may put women with a history of gestational diabetes mellitus (GDM) at risk of nonalcoholic fatty liver disease (NAFLD), as shown in a small prospective study.
